CCR4 and breast cancer: Given that CCR4 is expressed on >90% of Treg cells, as shown by Gobert et al. through an FACS analysis of CCR4 expression on peripheral T cells of healthy patients and breast cancer patients, Marshall et al. examined the impact of CCL17 and CCL22 on Treg accumulation in the PDAC TME [155,156].